Groundbreaking Achievement: Study of Ensartinib as Postoperative Adjuvant Therapy Published in The New England Journal of Medicine

Data ReadoutpositiveensartinibPositive

AI Analysis

Summary

Betta's ensartinib demonstrated positive results in the ELEVATE study for postoperative adjuvant therapy in ALK-positive NSCLC, with findings published in The New England Journal of Medicine.

Clinical Trial Data

Outcome Details

ELEVATE study published in The New England Journal of Medicine

Importance:6/10

Sentiment:

0.75

oncologylung cancerALK-positiveadjuvant therapyclinical trialpublication

Related Companies

$SHWZ $HGZDY $CHHE

Read the original article

Published by PR Newswire Pharma on July 9, 2026 2:16 AM

Read Original